Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Mallinckrodt's Abuse-Deterrent Oxycodone IR May Face Hurdle At US FDA Panel

Nov 11 2018

• By Brenda Sandburg

Oxycodone is the generic name for a range of opoid pain killing tablets. Prescription bottle for Oxycodone tablets and pills on metal table for opioid epidemic illustration

Related Content

Trevena's IV Opioid Not Quite 'Ready for Primetime,' US FDA Panel Concludes

Oct 12 2018

What's Missing In Intellipharmaceutics' Opioid Filing? FDA Panel Offers List

Jul 30 2017

Gottlieb Renews Call For New Opioid Review Paradigm As Democrats Prepare For House Control

Nov 09 2018

Not Another Opana: US FDA Panel Rejects PTI’s Remoxy On Intravenous Abuse Concerns

Jun 27 2018

Dsuvia Approval May Be Followed By New Opioid Review Paradigm At FDA

Nov 02 2018

Related Companies

Mallinckrodt plc

Talphera, Inc.

Daiichi Sankyo Co., Ltd.

Inspirion Delivery Technologies LLC

Trevena Inc.

Cassava Sciences, Inc.

Intellipharmaceutics International Inc.

Additional Topics

United States Advisory Committees Regulation FDA Neurology BioPharmaceutical

More from US FDA Performance Tracker

More from Regulatory Trackers

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window